These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 19501717)

  • 1. The molecular and cellular pathogenesis of dementia of the Alzheimer's type an overview.
    Luque FA; Jaffe SL
    Int Rev Neurobiol; 2009; 84():151-65. PubMed ID: 19501717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease: beta-Amyloid protein and tau.
    Morishima-Kawashima M; Ihara Y
    J Neurosci Res; 2002 Nov; 70(3):392-401. PubMed ID: 12391602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
    Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
    Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease: from molecular biology to neuropsychiatry.
    Cummings JL
    Semin Clin Neuropsychiatry; 2003 Jan; 8(1):31-6. PubMed ID: 12567330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau.
    Hardy J; Duff K; Hardy KG; Perez-Tur J; Hutton M
    Nat Neurosci; 1998 Sep; 1(5):355-8. PubMed ID: 10196523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Conformationally altered proteins cause neurodegenerative diseases].
    Ingelsson M; Nilsson L; Basun H; Aquilonius SM; Lannfelt L
    Lakartidningen; 2005 Nov 21-27; 102(47):3542-3, 3545-6, 3549 passim. PubMed ID: 16408392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advances in molecular pathology of Alzheimer's disease].
    Coria-Balanzat F
    Rev Neurol; 2006 Mar 1-15; 42(5):306-9. PubMed ID: 16538595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular basics of Alzheimer's disease].
    Grigorenko AP; Rogaev EI
    Mol Biol (Mosk); 2007; 41(2):331-45. PubMed ID: 17514900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological metals and Alzheimer's disease: implications for therapeutics and diagnostics.
    Duce JA; Bush AI
    Prog Neurobiol; 2010 Sep; 92(1):1-18. PubMed ID: 20444428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal models of Alzheimer's disease and frontotemporal dementia.
    Götz J; Ittner LM
    Nat Rev Neurosci; 2008 Jul; 9(7):532-44. PubMed ID: 18568014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease. A new take on tau.
    Marx J
    Science; 2007 Jun; 316(5830):1416-7. PubMed ID: 17556561
    [No Abstract]   [Full Text] [Related]  

  • 12. The modulation of metal bio-availability as a therapeutic strategy for the treatment of Alzheimer's disease.
    Crouch PJ; White AR; Bush AI
    FEBS J; 2007 Aug; 274(15):3775-83. PubMed ID: 17617225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathology of Alzheimer's disease.
    Carter J; Anderton B
    Br J Hosp Med; 1994 May 18-31; 51(10):522-8. PubMed ID: 7921490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stress proteins in Alzheimer's disease.
    Smith RC; Rosen KM; Pola R; Magrané J
    Int J Hyperthermia; 2005 Aug; 21(5):421-31. PubMed ID: 16048839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases.
    Ferreira ST; Vieira MN; De Felice FG
    IUBMB Life; 2007; 59(4-5):332-45. PubMed ID: 17505973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Nature-inspired' drug-protein complexes as inhibitors of Abeta aggregation.
    Bose M; Gestwicki JE; Devasthali V; Crabtree GR; Graef IA
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):543-7. PubMed ID: 16042540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAG-1M is up-regulated in hippocampus of Alzheimer's disease patients and associates with tau and APP proteins.
    Elliott E; Laufer O; Ginzburg I
    J Neurochem; 2009 May; 109(4):1168-78. PubMed ID: 19317853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The mechanisms of pathogenesis in Alzheimer's disease].
    Li L
    Sheng Li Ke Xue Jin Zhan; 1998 Oct; 29(4):345-8. PubMed ID: 12501666
    [No Abstract]   [Full Text] [Related]  

  • 20. Tau is central in the genetic Alzheimer-frontotemporal dementia spectrum.
    Dermaut B; Kumar-Singh S; Rademakers R; Theuns J; Cruts M; Van Broeckhoven C
    Trends Genet; 2005 Dec; 21(12):664-72. PubMed ID: 16221505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.